Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca
(Adnkronos) – SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This
